Clinical Trials Logo

Filter by:
NCT ID: NCT02020122 Completed - Pain Clinical Trials

Pain Prevention and Treatment Through the Enhancement of the Anti-nociceptive Component of Pain Modulation Profiles

Start date: January 2014
Phase: N/A
Study type: Interventional

To utilize the plasticity of the central pain pathways in order to (i) shift individuals with a pro-nociceptive pain modulation profile towards an anti-nociceptive one, and (ii) assess its relevance in minimizing pain-derived morbidity.

NCT ID: NCT02018692 Not yet recruiting - Clinical trials for Retinitis Pigmentosa

The Effect of Oral Administration of 9-cis Rich Powder of the Alga Dunaliella Bardawil on Visual Functions in Adolescent Patients With Retinitis Pigmentosa

Start date: March 1, 2025
Phase: Phase 1/Phase 2
Study type: Interventional

The aim of this study is to determine whether 9-cis-beta Caroten rich D. Brdawiil extract is effective in the treatment of retinitis pigmentosa in adolescent patients.

NCT ID: NCT02018328 Not yet recruiting - Clinical trials for Positivity for Helicobacter Pylori

The Impact of Addition of Curcumin for 10 Days Triple Therapy, on the Eradication Rate of Helicobacter Pylori Infection

CurHP
Start date: January 2014
Phase: N/A
Study type: Interventional

Background and Aims - H.pylori is a common human pathogen by which almost 50% of the world population is infected. According to the accepted guidelines, once H.pylori infection has been diagnosed,first line therapy with three drugs should be given. The triple treatment includes proton-pump-inhibitor-clarithromycin-amoxicillin but its eradication rate is only 70-80%. - Curcumin has many beneficial merits and it was also been demonstrated to be efficient in inhibition of H.pylori infection, in vitro.Therefore we aim to investigate whether addition of Curcumin to the standard triple therapy will increase the eradication rate of H.pylori infection. Methods - 150 consecutive patients that will undergo esophagogastroscopy in our Gastroenterology department and will be positive for H.pylori according to urease test and then by gastric biopsy, will be included. The patients will be randomized to two different treatments, according to binomial distribution. 75 patients will be treated with the standard triple therapy for 10 days and the other 75, will be treated for 10 days, with triple therapy combined with Curcumin that will be given three times a day. - During the treatment the patients will complete an adverse effect's questionnaires. 6 weeks after the completion of the treatment the patients will undergo urea breath test to confirm eradication. Patients will be asked to avoid antibiotics, bismuth compounds or proton-pump-inhibitor until the second urea-breath-test. - We will compare the eradication rate and the adverse effects between the two groups by using SPSS

NCT ID: NCT02017184 Not yet recruiting - Clinical trials for Body Temperature Regulation

Non-invasive Sensor for Core Temperature Measurement

Drager
Start date: December 2013
Phase: N/A
Study type: Interventional

Soldiers are required to perform and maintain alertness in difficult environmental conditions. The sensor examined in this trail may indicate body core temperature elevation during exertion. 12 male volunteers will arrive to our lab and perform a protocol of sitting and walking in thermoneutral and hot environments with two core temperature sensors. The results obtained from them will be compared.

NCT ID: NCT02017093 Completed - Stroke Clinical Trials

Error Enhancement of the Velocity Component

Start date: January 2009
Phase: N/A
Study type: Interventional

The purpose of this pilot study was to explore the impact of enhancement of the velocity component error in the course of reaching movements of the impaired/hemiparetic limb in an acute stroke subject. We hypothesized that the method would shift velocity profiles toward the optimal, resulting in a reduction in error. A prototype robot. This robotic device system has a two-dimensional motor, basic measurement capacities, and a robotic arm which is engaged to the subject's upper-limb in a sitting position. The enhancement of the velocity component error would shift velocity profiles toward the optimal, resulting in a reduction in error.

NCT ID: NCT02017054 Withdrawn - Clinical trials for Injury of Radial Artery

Feasibility and Outcomes of Repetitive Radial Approach

Start date: January 2015
Phase: N/A
Study type: Observational [Patient Registry]

The purpose of this study is to assess the feasibility of performing repetitive coronary angiograms via the radial approach

NCT ID: NCT02017028 Withdrawn - Clinical trials for Injury; Blood Vessel, Wrist, Radial Artery

Correlation Between Endothelial Function and Trans Radial-procedural Events

Start date: January 2015
Phase:
Study type: Observational [Patient Registry]

The aim of this study is to investigate the relation between the previous presence of endothelial dysfunction and the development of radial artery vasospasm during the trans-radial coronary evaluation.

NCT ID: NCT02016976 Not yet recruiting - Pain Clinical Trials

Effect of Local Anesthetic EMLA (Lidocaine 2.5% and Prilocaine 2.5%) Cream and Reduction in Dose, Pain and Intravenous Analgesic During Permanent Pacemaker Implantation

Start date: January 2014
Phase: N/A
Study type: Interventional

The investigators believe that the local anesthetic EMLA (Lidocaine 2.5% and Prilocaine 2.5%) cream will lessen pain and reduce the need for anesthesia and analgesia, when implanting a permanent pacemaker.

NCT ID: NCT02016859 Not yet recruiting - Clinical trials for Critically Ill Patients

Observational Prospective Study of the Predicted Value of Immature Thrombocytes Counts in Three Different Groups of Critically Ill Patients

Start date: January 2014
Phase: N/A
Study type: Observational [Patient Registry]

Immature Platelet Fraction (IPF) is a new value in CBC blood tests Recent Studies showed that this value may be another prognostic factor in critically ill patients such as those admitted to ICU, or those with neutropenic Fever. The purpose of the study is to check if the IPF may be used as a prognostic Factor in these patients

NCT ID: NCT02016846 Not yet recruiting - Clinical trials for Glucocorticoid Induced Hyperglycemia

Liraglutide Efficacy on Glucocorticoid Induced Hyperglycemia in Patients High Risk for Diabetes

Start date: January 2014
Phase: Phase 3
Study type: Interventional

Glucocorticoids therapy exposes the patient to an increased risk for diabetes morbidity. However, there is no proven preventive therapy. GLP-1-RA has shown to improve glucose metabolism in healthy volunteers treated with glucocorticoids. We assume that GLP-1-RA will improve glucose metabolism in patients with high risk for diabetes morbidity, treated with glucocorticoids.